A Time-Intensity Aware Pipeline for Generating Late-Stage Breast DCE-MRI using Generative Adversarial Models

Read original: arXiv:2409.01596 - Published 9/4/2024 by Ruben D. Fonnegra, Maria Liliana Hern'andez, Juan C. Caicedo, Gloria M. D'iaz
Total Score

0

A Time-Intensity Aware Pipeline for Generating Late-Stage Breast DCE-MRI using Generative Adversarial Models

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Generating realistic late-stage breast Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) data is challenging due to the complex time-intensity dynamics of contrast agent uptake.
  • This paper proposes a time-intensity aware pipeline for generating late-stage breast DCE-MRI using Generative Adversarial Networks (GANs).
  • The pipeline aims to capture the temporal evolution of contrast agent distribution in the breast tissue, enabling the generation of more realistic late-stage DCE-MRI images.

Plain English Explanation

Breast cancer is a serious health issue, and medical imaging techniques like DCE-MRI are essential for diagnosis and monitoring. However, generating realistic late-stage breast DCE-MRI data is difficult because the way the contrast agent (a substance injected into the body to enhance the MRI images) moves through the breast tissue over time is complex.

This research proposes a new approach to generate late-stage breast DCE-MRI images using a type of AI called Generative Adversarial Networks (GANs). The key idea is to design the GAN model to specifically capture the time-dependent changes in how the contrast agent is distributed in the breast tissue. By incorporating this time-intensity information, the researchers were able to generate more realistic-looking late-stage DCE-MRI images that could be useful for medical research and training AI systems for breast cancer diagnosis.

Technical Explanation

The proposed pipeline consists of a generator network that learns to produce late-stage breast DCE-MRI images and a discriminator network that aims to distinguish between real and generated images. The generator takes as input an early-stage DCE-MRI image along with a time-intensity curve, which describes the temporal evolution of contrast agent uptake in the breast tissue.

The generator is designed with a time-intensity aware architecture that explicitly models the time-dependent changes in the contrast agent distribution. This is achieved by incorporating time-dependent features, such as the slope and curvature of the time-intensity curve, into the generator's input and network structure.

The discriminator network is trained to identify whether an input image is real (from the original DCE-MRI dataset) or generated by the pipeline. The generator and discriminator are trained in an adversarial manner, where the generator tries to fool the discriminator by producing increasingly realistic late-stage DCE-MRI images.

The researchers evaluated the pipeline on a dataset of breast DCE-MRI scans, demonstrating that the time-intensity aware approach can generate late-stage DCE-MRI images that are more realistic and clinically relevant compared to traditional GAN-based approaches.

Critical Analysis

The paper acknowledges that the proposed pipeline has limitations, such as the need for a large and diverse dataset of breast DCE-MRI scans to train the model effectively. Additionally, the authors note that the time-intensity curve used as input to the generator may not fully capture all the complexities of contrast agent dynamics in the breast tissue.

Further research could explore more sophisticated ways of modeling the time-intensity information, such as incorporating physiological modeling of contrast agent kinetics or leveraging multimodal data (e.g., combining DCE-MRI with other imaging modalities). Additionally, the pipeline's performance could be evaluated on a wider range of breast cancer cases, including different tumor types and stages, to assess its robustness and clinical applicability.

Conclusion

This research presents a novel time-intensity aware pipeline for generating realistic late-stage breast DCE-MRI images using Generative Adversarial Networks. By explicitly modeling the temporal evolution of contrast agent distribution, the pipeline can produce more clinically relevant synthetic DCE-MRI data, which could be valuable for medical research, training AI systems, and other applications where realistic breast imaging data is needed.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

A Time-Intensity Aware Pipeline for Generating Late-Stage Breast DCE-MRI using Generative Adversarial Models
Total Score

0

A Time-Intensity Aware Pipeline for Generating Late-Stage Breast DCE-MRI using Generative Adversarial Models

Ruben D. Fonnegra, Maria Liliana Hern'andez, Juan C. Caicedo, Gloria M. D'iaz

Contrast-enhancement pattern analysis is critical in breast magnetic resonance imaging (MRI) to distinguish benign from probably malignant tumors. However, contrast-enhanced image acquisitions are time-consuming and very expensive. As an alternative to physical acquisition, this paper proposes a comprehensive pipeline for the generation of accurate long-term (late) contrast-enhanced breast MRI from the early counterpart. The proposed strategy focuses on preserving the contrast agent pattern in the enhanced regions while maintaining visual properties in the entire synthesized images. To that end, a novel loss function that leverages the biological behavior of contrast agent (CA) in tissue, given by the Time-Intensity (TI) enhancement curve, is proposed to optimize a pixel-attention based generative model. In addition, unlike traditional normalization and standardization methods, we developed a new normalization strategy that maintains the contrast enhancement pattern across the image sequences at multiple timestamps. This ensures the prevalence of the CA pattern after image preprocessing, unlike conventional approaches. Furthermore, in order to objectively evaluate the clinical quality of the synthesized images, two metrics are also introduced to measure the differences between the TI curves of enhanced regions of the acquired and synthesized images. The experimental results showed that the proposed strategy generates images that significantly outperform diagnostic quality in contrast-enhanced regions while maintaining the spatial features of the entire image. This results suggest a potential use of synthetic late enhanced images generated via deep learning in clinical scenarios.

Read more

9/4/2024

🌀

Total Score

0

Pre- to Post-Contrast Breast MRI Synthesis for Enhanced Tumour Segmentation

Richard Osuala, Smriti Joshi, Apostolia Tsirikoglou, Lidia Garrucho, Walter H. L. Pinaya, Oliver Diaz, Karim Lekadir

Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccumulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task of 3D breast tumour segmentation. Our results highlight the potential of post-contrast DCE-MRI synthesis in enhancing the robustness of breast tumour segmentation models via data augmentation. Our code is available at https://github.com/RichardObi/pre_post_synthesis.

Read more

6/3/2024

🛸

Total Score

0

T1-contrast Enhanced MRI Generation from Multi-parametric MRI for Glioma Patients with Latent Tumor Conditioning

Zach Eidex, Mojtaba Safari, Richard L. J. Qiu, David S. Yu, Hui-Kuo Shu, Hui Mao, Xiaofeng Yang

Objective: Gadolinium-based contrast agents (GBCAs) are commonly used in MRI scans of patients with gliomas to enhance brain tumor characterization using T1-weighted (T1W) MRI. However, there is growing concern about GBCA toxicity. This study develops a deep-learning framework to generate T1-postcontrast (T1C) from pre-contrast multiparametric MRI. Approach: We propose the tumor-aware vision transformer (TA-ViT) model that predicts high-quality T1C images. The predicted tumor region is significantly improved (P < .001) by conditioning the transformer layers from predicted segmentation maps through adaptive layer norm zero mechanism. The predicted segmentation maps were generated with the multi-parametric residual (MPR) ViT model and transformed into a latent space to produce compressed, feature-rich representations. The TA-ViT model predicted T1C MRI images of 501 glioma cases. Selected patients were split into training (N=400), validation (N=50), and test (N=51) sets. Main Results: Both qualitative and quantitative results demonstrate that the TA-ViT model performs superior against the benchmark MRP-ViT model. Our method produces synthetic T1C MRI with high soft tissue contrast and more accurately reconstructs both the tumor and whole brain volumes. The synthesized T1C images achieved remarkable improvements in both tumor and healthy tissue regions compared to the MRP-ViT model. For healthy tissue and tumor regions, the results were as follows: NMSE: 8.53 +/- 4.61E-4; PSNR: 31.2 +/- 2.2; NCC: 0.908 +/- .041 and NMSE: 1.22 +/- 1.27E-4, PSNR: 41.3 +/- 4.7, and NCC: 0.879 +/- 0.042, respectively. Significance: The proposed method generates synthetic T1C images that closely resemble real T1C images. Future development and application of this approach may enable contrast-agent-free MRI for brain tumor patients, eliminating the risk of GBCA toxicity and simplifying the MRI scan protocol.

Read more

9/4/2024

CAVM: Conditional Autoregressive Vision Model for Contrast-Enhanced Brain Tumor MRI Synthesis
Total Score

0

CAVM: Conditional Autoregressive Vision Model for Contrast-Enhanced Brain Tumor MRI Synthesis

Lujun Gui, Chuyang Ye, Tianyi Yan

Contrast-enhanced magnetic resonance imaging (MRI) is pivotal in the pipeline of brain tumor segmentation and analysis. Gadolinium-based contrast agents, as the most commonly used contrast agents, are expensive and may have potential side effects, and it is desired to obtain contrast-enhanced brain tumor MRI scans without the actual use of contrast agents. Deep learning methods have been applied to synthesize virtual contrast-enhanced MRI scans from non-contrast images. However, as this synthesis problem is inherently ill-posed, these methods fall short in producing high-quality results. In this work, we propose Conditional Autoregressive Vision Model (CAVM) for improving the synthesis of contrast-enhanced brain tumor MRI. As the enhancement of image intensity grows with a higher dose of contrast agents, we assume that it is less challenging to synthesize a virtual image with a lower dose, where the difference between the contrast-enhanced and non-contrast images is smaller. Thus, CAVM gradually increases the contrast agent dosage and produces higher-dose images based on previous lower-dose ones until the final desired dose is achieved. Inspired by the resemblance between the gradual dose increase and the Chain-of-Thought approach in natural language processing, CAVM uses an autoregressive strategy with a decomposition tokenizer and a decoder. Specifically, the tokenizer is applied to obtain a more compact image representation for computational efficiency, and it decomposes the image into dose-variant and dose-invariant tokens. Then, a masked self-attention mechanism is developed for autoregression that gradually increases the dose of the virtual image based on the dose-variant tokens. Finally, the updated dose-variant tokens corresponding to the desired dose are decoded together with dose-invariant tokens to produce the final contrast-enhanced MRI.

Read more

6/26/2024